Home » MOL2NET-1 » Section b: Medicinal Chemistry, Pharmacology, Biotechnology, and Drug Discovery

MOL2NET, International Conference on Multidisciplinary Sciences

B: Medicinal Chemistry, Pharmacology, Biotechnology, and Drug Discovery

This section covers: Experimental and theoretical methods applied to drug discovery, biomarkers and target validation, vaccine design, in biosciences. In experimental studies: Pharmacological assays, Toxicity and Cytotoxicity studies, Molecular Biology and Biotechnology. Proteomics, Genomics, and Metabolomics (OMICS methods) like Sequencing, Cloning, DNA microarrays, and Mass Spectroscopy in Clinical Proteomics.  Also, theoretical studies:  Molecular Mechanics and Molecular Dynamics (MM/MD) for Drug-protein Docking studies, Quantitative Structure-Activity / Toxicity Relationships (QSAR / QSTR) models. Bioinformatics analysis of Disease Biomarkers and Computational vaccine design (Alignment and Alignment-free techniques). Determination of the 3D proteins structure using NMR and X-ray techniques. Experimental and computational study of RNA (Rnomics), secondary RNA structure prediction, miRNA biomarkers.

List of presentations (38)
List of Accepted Abstracts (5)
The microRNA regulatory network: a far-reaching approach to theregulate the Wnt signaling pathway in number of diseases
Anxiolytic-like effects of 7H-benzo[e]perimidin-7-one derivatives through elevated plus-maze test in mice
Computational prediction of thermolysin inhibitors using multiple linear regression according to OECD principles
Modeling the interactions between mitochondrial voltage-dependent anion cannel (VDAC) and single walled carbon nanotubes using molecular docking simulation with virtual screening framework
Two QSAR Paradigms- Congenericity Principle versus Diversity Begets Diversity Principle- analyzed using computed mathematical chemodescriptors of homogeneous and diverse sets of chemical mutagens.